Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract

Cancer

Volumn 86, Issue 10, 1999, Pages 2109-2116

  Nakanishi, Kuniaki ^a   Kawai, Toshiaki ^a   Hiroi, Sadayuki ^a   Kumaki, Fumiyuki ^a   Torikata, Chikao ^a   Aurues, Takashi ^a   Ikeda, Tomosumi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Telomerase RNA component (hTR); Transitional cell carcinoma; Upper urinary tract

Indexed keywords

MESSENGER RNA; TELOMERASE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CYSTECTOMY; ENZYME ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; RNA ANALYSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0033571620     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2109::AID-CNCR32>3.0.CO;2-6     Document Type: Article

References (41)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomerase shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
3. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995;269:1267-72.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
5. Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, Han W, et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst 1997;89:1609-15.
6. Sallinen P, Miettinen H, Sallinen S-L, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997;150:1159-64.
7. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
8. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
9. Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996;12 :200-4.
10. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-50.
11. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistsuba II, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-7.
12. Yashima K, Piatyszek MA, Saboorian HW, Virmani AK, Brown D, Shay JW, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-7.
13. Yashima K, Ashfaq R, Nowak J, von Gruenigen V, Milchgrub S, Rathi A, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998;82:1319-27.
14. ink4 and telomerase in immortalisation of human cells. Oncogene 1995;11:971-6.
15. Whynford-Thomas D, Bond JA, Wyllie FS, Jones CJ. Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog 1995;12:119-23.
16. Parkinson EK, Newbold RF, Keith WN. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur J Cancer 1997;33:727-34.
17. Kamata S, Kageyama Y, Yonese J, Oshima H. Significant telomerase reduction in human superficial transitional cell carcinoma. Br J Urol 1996;78:704-8.
18. Kyo S, Kunimi K, Uchibayashi T, Namiki M, Inoue M. Telomerase activity in human urothelial tumors. Am J Clin Pathol 1997;107:555-60.
19. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997;79:362-9.
20. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997;89:724-30.
21. Linn JF, Lango M, Halachmi S, Schoenberg MP, Sidransky D. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer 1997;74:625-9.
22. Heine B, Hummel M, Muller M, Heicappell R, Miller K, Stein H. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J Pathol 1998;184:71-6.
23. Lee D-H, Yang S-C, Hong S-J, Chung B-H, Kim IY. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Clin Cancer Res 1998;14:535-8.
24. Nakanishi K, Kawai T, Torikata C. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Hum Pathol 1996;27:1336-40.
25. Nakanishi K, Hiroi S, Kawai T, Torikata C. Expression of platelet-derived growth factor B-chain mRNA and tumor angiogenesis in invasive transitional cell carcinoma of the upper urinary tract. Mod Pathol 1997;10:341-7.
26. Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Virchows Arch 1998; 432:445-50.
27. UICC (International Union Against Cancer). Renal pelvis and ureter. In: Illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd edition, 2nd revision. Berlin: Springer-Verlag, 1992:270-3.
28. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology. 3rd Series, Fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1994:202-19.
29. SAS technical report P-217. SAS/STAT software. The PHREG Procedure. Version 6. Cary, NC: SAS Institute Inc., 1991:63.
30. Akaza H, Koiso K, Niijima T. Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 1987;59:1369-75.
31. Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988;62:2016-20.
32. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. Tumor specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene 1998;16:979-83.
33. Brien TP, Kallakury BVS, Lowry CV, Ambros RA, Muraca PJ, Malfetano JH, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 1997;57:2760-4.
34. Brocon T, Aldous W, Lance R, Blaser J, Baker T, Williard W. The association between telomerase, p53, and clinical staging in colorectal cancer. Am J Surg 1998;175:364-6.
35. Milas M, Yu D, Sun DT, Pollock RE. Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status. Clin Cancer Res 1998;4:1573-9.
36. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997;57:610-4.
37. Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R, et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 1997;231:610-4.
38. Rushing EJ, Yashima K, Brown D, White CL III, Shay JM, Risser RC, et al. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 1997;56:1142-6.
39. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18:65-8.
40. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998;19:182-6.
41. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998;58:1558-61.